Over the 90-day window ending February 10, 2026, Ocular Therapeutix's three dominant insider ownership positions are held by TenPercentOwner Road Llc Summer (8.59Mn shares), Director Pravin Dugel (3.46Mn shares), President And Ceo Antony C. Mattessich (595.20K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Road Llc Summer | 8,591,401 | 27 Feb, 2024 | |
| Pravin Dugel | Nan | 3,458,075 | 26 Nov, 2025 |
| Antony C. Mattessich | President And Ceo | 595,201 | 06 Feb, 2024 |
| Donald Notman | Chief Operating Officer | 377,802 | 04 Feb, 2026 |
| Sanjay Nayak | Chief Strategy Officer | 342,760 | 06 Jan, 2026 |
| Jeffrey S. Heier | Chief Scientific Officer | 326,425 | 06 Jan, 2026 |
| Nadia Waheed | Chief Medical Officer | 326,280 | 06 Jan, 2026 |
| Michael H. Goldstein | President And Ophthalmology & Cmo | 313,335 | 07 Feb, 2022 |
| Peter Kaiser | Chief Development Officer | 271,918 | 06 Jan, 2026 |
| Namrata Saroj | Chief Business Officer | 254,620 | 06 Jan, 2026 |
| Steve Lawrence Meyers | Chief Commercial Officer | 217,628 | 06 Jan, 2026 |
| Philip C. Strassburger | General Counsel | 161,493 | 06 Feb, 2024 |
| Rabia Gurses Ozden | Chief Medical Officer | 153,054 | 06 Feb, 2024 |
| Todd Anderman | Chief Legal Officer | 152,468 | 06 Jan, 2026 |
| Richard L Md Lindstrom | 143,145 | 13 Jun, 2025 | |
| David Wayne Robinson | Global Cco | 136,000 | 26 Jan, 2026 |
| Christopher G White | Chief Business Officer | 123,689 | 06 Feb, 2024 |
| Charles M Warden | 86,464 | 13 Jun, 2025 | |
| Leslie J. Williams | 51,433 | 13 Jun, 2025 | |
| Adrienne L Graves | 50,000 | 13 Jun, 2025 | |
| Seung Suh Hong | 46,933 | 13 Jun, 2025 | |
| Merilee Raines | 46,933 | 13 Jun, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 04 Feb, 2026 | Donald Notman | Common Stock | D | 6,035 | $8.54 | 377,802 | D | S |
| 02 Feb, 2026 | Donald Notman | Common Stock | D | 5,455 | $9.14 | 383,837 | D | S |
| 21 Jan, 2026 | David Wayne Robinson | Common Stock | A | 136,000 | $0.00 | 136,000 | D | A |
| 02 Jan, 2026 | Jeffrey S. Heier | Common Stock | A | 79,112 | $0.00 | 326,425 | D | A |
| 02 Jan, 2026 | Donald Notman | Common Stock | A | 79,112 | $0.00 | 389,292 | D | A |
| 02 Jan, 2026 | Peter Kaiser | Common Stock | A | 79,112 | $0.00 | 271,918 | D | A |
| 02 Jan, 2026 | Sanjay Nayak | Common Stock | A | 64,900 | $0.00 | 342,760 | D | A |
| 02 Jan, 2026 | Nadia Waheed | Common Stock | A | 79,112 | $0.00 | 326,280 | D | A |
| 02 Jan, 2026 | Todd Anderman | Common Stock | A | 64,900 | $0.00 | 152,468 | D | A |
| 02 Jan, 2026 | Namrata Saroj | Common Stock | A | 79,112 | $0.00 | 254,620 | D | A |
| 02 Jan, 2026 | Steve Lawrence Meyers | Common Stock | A | 64,900 | $0.00 | 217,628 | D | A |
| 26 Nov, 2025 | Pravin Dugel | - | - | 0 | I | |||
| 26 Nov, 2025 | Pravin Dugel | Common Stock | A | 49,754 | $0.00 | 300,115 | I | G |
| 26 Nov, 2025 | Pravin Dugel | - | - | 300,115 | I | |||
| 26 Nov, 2025 | Pravin Dugel | Common Stock | D | 49,754 | $0.00 | 0 | I | G |
| 24 Nov, 2025 | Jeffrey S. Heier | Common Stock | D | 3,469 | $12.04 | 245,940 | D | S |
| 24 Nov, 2025 | Pravin Dugel | - | - | 3,157,960 | D | |||
| 24 Nov, 2025 | Pravin Dugel | Common Stock | D | 19,530 | $12.04 | 3,157,960 | D | S |
| 24 Nov, 2025 | Peter Kaiser | Common Stock | D | 3,007 | $12.02 | 191,433 | D | S |
| 24 Nov, 2025 | Sanjay Nayak | Common Stock | D | 1,878 | $12.04 | 277,860 | D | S |